NPI: 1013102110 · GREENWOOD, IN 46143 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/11/2007
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 09/11/2007 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,523 | $85K |
| 2019 | 10,099 | $140K |
| 2020 | 9,285 | $126K |
| 2021 | 20,150 | $285K |
| 2022 | 27,154 | $367K |
| 2023 | 14,574 | $747K |
| 2024 | 8,484 | $327K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 47,622 | 2,203 | $1.91M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 25,426 | 916 | $87K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,303 | 474 | $60K |
| J1756 | Injection, iron sucrose, 1 mg | 5,929 | 936 | $16K |
| A4657 | Syringe, with or without needle, each | 4,715 | 1,184 | $4K |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,862 | 443 | $3K |
| 83970 | 988 | 551 | $89.27 | |
| 82728 | 1,266 | 702 | $48.89 | |
| 85041 | 1,739 | 920 | $40.83 | |
| 85048 | 1,661 | 890 | $40.22 | |
| 83550 | 1,054 | 592 | $37.92 | |
| 83540 | 1,306 | 736 | $35.86 | |
| G0008 | Administration of influenza virus vaccine | 98 | 55 | $16.61 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 211 | 71 | $0.00 |
| 0011A | 21 | 14 | $0.00 | |
| 0012A | 15 | 13 | $0.00 | |
| 90674 | 27 | 18 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 26 | 12 | $0.00 |